TOP　>　News Release

News Release

November 13, 2024: Otsuka Pharmaceutical Factory and ICU Medical Announce the Establishment of Joint Venture
October 29, 2024: Supply of Renewable Energy to Business Partners -Towards Achieving Carbon Neutrality Throughout Our Supply Chain-
September 30, 2024: EN Otsuka Pharmaceutical Co., Ltd. obtains marketing approval of "ENOSOLID Semi Solid for Enteral Use"
September 24, 2024: Otsuka Pharmaceutical Factory obtains marketing approval of "KIDPAREN Injection," the amino acid, glucose, electrolyte, fat, and multivitamin injection for high calorie parenteral nutrition of patients with chronic kidney disease
September 10, 2024: Otsuka Pharmaceutical Factory launches additional OS-1 Jelly Apple Flavor 200 g to the Oral Rehydration Solution OS-1 series
August 26, 2024: Otsuka Pharmaceutical Factory to Start Distributing an App "Nurtal" to Visualize Administration of Nutrition and Support Nutrition Management by Healthcare Professionals
July 29, 2024: Otsuka Pharmaceutical Factory to Build a New Factory "MP-PS" for Stable Supply of Prefilled Syringes
February 14, 2024: Otsuka Pharmaceutical Factory launches a concentrated liquid diet product "HINEX^Ⓡ Jelly" as a new product with improved compositions and physical properties
February 7, 2024: Otsuka Group Selected for CDP Climate Change A List for a Second Consecutive Year
January 31, 2024: Otsuka Pharmaceutical Factory acquired all the shares and one hundred percent ownership of Neuroceuticals Okinawa
January 9, 2024: Donations to Support Relief Efforts Following the Noto Peninsula Earthquake
January 9, 2024: Otsuka Pharmaceutical Factory concluded the share transfer agreement with Neuroceuticals to acquire all the shares of Neuroceuticals Okinawa
December 13, 2023: Otsuka Pharmaceutical Factory relaunches HINORA^Ⓡ medicated toothpaste (quasi-drug) and HINORA^Ⓡ Moisture Gel (oral cosmetic)
November 6, 2023: Otsuka Pharmaceutical Factory Announces Personnel Changes
November 6, 2023: Otsuka Announces Personnel Changes
September 13, 2023: Otsuka Pharmaceutical Factory launches "Tumguide^Ⓡ LED Light Source" and "Tumguide^Ⓡ Fiber" as medical devices that configure "Tumguide^Ⓡ," a device for checking the position of the nasogastric tube tip
July 25, 2023: Otsuka Pharmaceutical Factory launches a concentrated liquid diet product "HINEX RENUTE^Ⓡ" to provide protein and energy for early resumption of nutrition
June 28, 2023: Otsuka Pharmaceutical Factory receives the Asia-Pacific Gel Immersion Endoscopy New Product Innovation Award of the 2023 Best Practice Award from Frost & Sullivan
May 23, 2023: Otsuka Pharmaceutical Factory launches additional 200 kcal/125 mL standard with coffee flavor and tea flavor to ENORAS^Ⓡ Liquid for Enteral Use (for feeding tube and oral administration)
May 2, 2023: Otsuka Pharmaceutical Factory completes acquisition of additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited
April 27, 2023: Otsuka Techno launches OT-Algae, a resin-bag type microalgae culture device as a part of environmentally friendly manufacturing
March 31, 2023: Otsuka Techno installs electricity derived from renewable energy at all domestic facilities aimed to realize a low-carbon society -Zeroing CO₂ emissions at all domestic facilities-
March 22, 2023: Otsuka Pharmaceutical Factory makes capital participation in Frontier Field Inc.
January 12, 2023: Announcement of price revisions for concentrated liquid diet foods and other products
December 13, 2022: Otsuka Group Selected for CDP Climate Change A List
December 12, 2022: Otsuka Pharmaceutical Factory launches Lilium one^Ⓡ, a medical device that measures urine volume in the bladder specialized for single measurement
November 21, 2022: Announcement of price revisions for the Oral Rehydration Solution OS-1^Ⓡ series
July 29, 2022: Otsuka Pharmaceutical Factory launches OT-Balloon Catheter^Ⓡ, an intermittent urological catheter
June 20, 2022: Otsuka Pharmaceutical Factory launches additional OS-1^Ⓡ Apple Flavor 300 mL and 500 mL to the Oral Rehydration Solution OS-1^Ⓡ series
June 17, 2022: Otsuka Pharmaceutical Factory begins to provide Pokenyu (Pocket Nutrition), a cloud service that helps professionals involved in home medical care identify and solve dietary and nutritional issues for home medical care patients
June 17, 2022: Otsuka Pharmaceutical Factory surveys the actual condition of dietary and nutritional care at home-visit nursing offices. Only about 8.2% determine undernutrition using objective "evaluation indicators (nutrition assessment tools)."
June 17, 2022: Otsuka Pharmaceutical Factory launches a vasopressin V₂-receptor antagonist "Tolvaptan OD tablets 7.5 mg Otsuka"
June 16, 2022: Otsuka Pharmaceutical Factory surveys the actual status regarding perceptions of water in the body (body fluid), dehydration, and heatstroke. Only about 18% of people are aware of the relationship between reduced food intake and dehydration.
May 12, 2022: Four Otsuka Group Companies in Indonesia Adopts CO₂-Free Electricity - Approximately 13% reduction in annual CO₂ emissions -
April 21, 2022: Otsuka Group Joins RE100 International Initiative 　- Committed to 100% Renewable Energy -
March 31, 2022: A healthcare appliance "Lilium-SPOT^Ⓡ2," which can easily check the amount of urine in the bladder using ultrasonic waves, is certified under "Kawasaki Innovation Standard"
February 10, 2022: Otsuka Pharmaceutical Factory introduces a cogeneration system that contributes to CO₂ emission reductions and stable supplies of pharmaceuticals to its Naruto Factory
January 14, 2022: Capital Alliance between Otsuka Pharmaceutical Factory and Neuroceuticals
December 20, 2021: Otsuka Pharmaceutical Factory launches Actreen, an intermittent urological catheter
November 4, 2021: Otsuka Group Supports Recommendations of the Task Force on Climate-related Financial Disclosure (TCFD) -Joins TCFD Consortium-
October 4, 2021: Otsuka Pharmaceutical Factory concludes an exclusive marketing agreement in Japan with B. Braun Aesculap for Actreen, an intermittent urological catheter
September 16, 2021: Lilium Otsuka launches a healthcare appliance, "Lilium-SPOT^Ⓡ2," as an improved version of "Lilium-SPOT^Ⓡ," which can easily check the amount of urine in the bladder using ultrasonic waves
September 1, 2021: 100th Anniversary of Otsuka Group of Companies Looking Ahead to the Next 100 Years
August 24, 2021: Otsuka Pharmaceutical Factory and Fujitsu begin exploratory joint research to develop AI services to predict risks of undernutrition in patients with National Cancer Center and National Center for Geriatrics and Gerontology
August 5, 2021: Otsuka Pharmaceutical Factory opens LINE official account for its Oral Rehydration Solution OS-1^Ⓡ Series - Providing information on dehydration and heatstroke in addition to product information -
July 2, 2021: Otsuka Techno launches a saliva collection funnel used for testing infectious diseases
June 9, 2021: Otsuka Group Complete Introduction of CO₂-free Electricity for All 23 Manufacturing Facilities in Japan -Contributing to a more than 40% reduction in annual CO₂ emissions in Japan-
June 7, 2021: Otsuka Pharmaceutical Factory launches "HINEX^Ⓡ E-Gel" and "HINEX^Ⓡ E-gel LC" as new products with changed names and compositions -Developing concentrated liquid diet products globally under the "HINEX" brand-
May 11, 2021: Egypt Otsuka to establish a new company jointly with a local company to provide IV solution business
April 22, 2021: Otsuka Techno launches OT-GLOVE, cold-resistant gloves for handling frozen vaccines
April 22, 2021: Otsuka Techno launches desk shield to prevent droplet infection
February 9, 2021: Office Divisions of Five Otsuka Group Companies to Switch to Green Power
November 26, 2020: Otsuka Pharmaceutical Factory launches ENEFLUID^Ⓡ Injection, the amino acid, glucose, electrolyte, fat, and water-soluble vitamin injection
November 25, 2020: Otsuka Pharmaceutical Factory receives the Mothers Selection Award 2020 for its Oronine^Ⓡ H Ointment
November 12, 2020: Otsuka Pharmaceutical Factory completes a new factory "MP-VII" for IV solutions, with the world's highest quality and a high production capacity
October 20, 2020: Otsuka Pharmaceutical Factory concludes a comprehensive collaborative agreement with Imizu City, Toyama
October 1, 2020: Otsuka Pharmaceutical Factory receives the Good Design Award 2020 for its Oral Rehydration Solution OS-1^Ⓡ Series
September 30, 2020: Otsuka Group Acquires ISO 14001 Certification -Reinforcement of group-wide environmental initiatives-
September 29, 2020: Otsuka Pharmaceutical Factory introduces a self-consuming solar power generation facility that contributes to CO₂ emission reductions to its Kushiro Factory
September 25, 2020: Otsuka Pharmaceutical Factory obtains marketing approval of ENEFLUID^Ⓡ Injection, the amino acid, glucose, electrolyte, fat, and water-soluble vitamin injection
September 11, 2020: Otsuka Pharmaceutical Factory launches VISCOCLEAR^Ⓡ, gel to secure the visual field that is used for the endoscope for natural opening
August 28, 2020: Otsuka Pharmaceutical Factory obtains approval of new labeling including “prevention of deterioration of or recovery from dehydration” and “heatstroke with dehydration” for its Oral Rehydration Solution OS-1^Ⓡ Series (individually evaluated food for persons with medical conditions) from the Consumer Affairs Agency
July 31, 2020: Otsuka Techno launches a new disposable face shield TEC-GUARD
July 3, 2020: Otsuka Pharmaceutical Factory launches oral care gel (medicated toothpaste) HINORA^Ⓡ (quasi-drug) and oral moisture gel HINORA^Ⓡ Moisture Gel (oral cosmetic)
June 24, 2020: Otsuka Pharmaceutical Factory obtains marketing approval of VISCOCLEAR^Ⓡ, gel to secure the visual field that is used for the endoscope for natural opening
June 12, 2020: Otsuka Pharmaceutical Factory launches new ENORAS^Ⓡ Liquid for Enteral Use (for feeding tube and oral administration),coffee flavor and strawberry flavor
February 26, 2020: Otsuka Pharmaceutical Factory concludes a comprehensive collaborative agreement with Kushiro City, Hokkaido, on creating a community where citizens can live a lively, healthy, and safe life
February 14, 2020: Five companies including Otsuka Pharmaceutical Factory have won the Minister of State for Science and Technology Policy Award in the 2nd Japan Open Innovation Prize
February 10, 2020: Otsuka Pharmaceutical Factory, Inc. introduces cogeneration system that contributes to CO₂ emission reductions and stable supplies of pharmaceuticals to its Toyama Factory
January 27, 2020: Otsuka Pharmaceutical Factory starts providing information to healthcare professionals to support Nursing Now, a global campaign to create the future through the power of nursing
January 24, 2020: Otsuka Pharmaceutical Factory opens Japan-India Institute for Manufacturing (JIM), certified by the Ministry of Economy, Trade and Industry, in Ahmedabad, India
October 11, 2019: Otsuka Techno Corporation completes a new factory "Naruto No. 3 Factory" for film products, with high quality and production capacity
September 26, 2019: Otsuka Pharmaceutical Factory develops Cellstor^Ⓡ-S cell suspension and preservation solution and Cellstor^Ⓡ-W cell wash and preservation solution - Research reagents leading to applications in regenerative medicine products -
September 13, 2019: Otsuka Pharmaceutical Factory launches a concentrated liquid diet product "Hine E-Gel^Ⓡ LC," a new line of "Hine E-Gel^Ⓡ" which changes from a liquid to a gel in the stomach
August 22, 2019: Otsuka Group Adopts CO₂-free Electricity―Annual CO₂ Emissions to Decline by Approximately 9%
June 10, 2019: Otsuka Techno establishes a new company in Vietnam to manufacture and market package materials for medical use
May 29, 2019: Otsuka Pharmaceutical Factory launches ENORAS^Ⓡ Liquid for Enteral Use (for feeding tube and oral administration)
May 10, 2019: Otsuka Pharmaceutical Factory concludes a comprehensive collaborative agreement with Naruto City (Tokushima) on creating a community where citizens can live a safe, healthy life
March 26, 2019: EN Otsuka Pharmaceutical obtains marketing approval of ENORAS^Ⓡ Liquid for Enteral Use (for feeding tube and oral administration)
February 18, 2019: Otsuka Pharmaceutical Factory launches a new Engelead^Ⓡ Grape Jelly (78-g size) for persons with difficulty swallowing
November 7, 2018: Otsuka Pharmaceutical Factory launches a new REHADAYS to support exercise and rehabilitation, fruit mix flavor
October 31, 2018: Lilium Otsuka launches a healthcare home appliance, "Lilium Spot", which can easily check urine volume in the bladder
October 30, 2018: Otsuka Pharmaceutical Factory starts joint development of regenerative medicine products with Adipo Medical Technology
September 19, 2018: Otsuka Pharmaceutical Factory files patent infringement lawsuit against AY Pharmaceuticals and Yoshindo
September 4, 2018: Lilium Otsuka's R&D project is selected for inclusion in FY 2018 Project to develop robotic devices for nursing care and set the standards (subsidized project for development) by AMED
June 14, 2018: Otsuka Pharmaceutical Factory launches the antiseptics for external use "Olanedine^Ⓡ Antiseptic Solution OR"
June 5, 2018: Otsuka Pharmaceutical Factory launches a new Racol-NF Liquid for Enteral Use (for feeding tube and oral administration), green tea flavor
April 27, 2018: Otsuka Pharmaceutical Factory acquires all the shares of Lilium Otsuka held by Otsuka Medical Devices, making it a whollyowned subsidiary
March 20, 2018: Otsuka Pharmaceutical Factory enters into an agreement to acquire additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited, making it a wholly owned subsidiary
February 26, 2018: Otsuka Pharmaceutical Factory receives "Platinum Kurumin" certification as excellent company providing childcare support
February 21, 2018: Otsuka Pharmaceutical Factory certified as Excellent Health and Productivity Management Enterprise 2018
January 25, 2018: Otsuka Pharmaceutical Factory enters into an agreement to acquire additional equity in New Zealand joint venture company, Diatranz Otsuka Limited
January 19, 2018: Otsuka Signs Statement of Support for Women's Empowerment Principles
December 25, 2017: Otsuka to invest in Megakaryon Corporation, with the aim to advance commercialization of iPS-cell-derived platelet preparations
September 21, 2017: Otsuka Pharmaceutical Factory completes acquisition of additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited
August 24, 2017: Otsuka Pharmaceutical Factory obtains import drug license of Cefazolin Sodium for Injection/Sodium Chloride Injection in China
August 23, 2017: Otsuka OPV, the Vietnamese subsidiary of Otsuka Pharmaceutical Factory announces the construction of a new factory for the distribution of high quality IV solution products
June 16, 2017: Otsuka Pharmaceutical Factory launches in Japan the anti-gastritis and anti-gastric ulcer agent "Rebamipide Tablets 100mg Otsuka"
May 8, 2017: Otsuka Pharmaceutical Factory enters into an agreement to acquire additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited (OPI)
November 25, 2016: Otsuka joins UN Global Compact
July 5, 2016: Otsuka Pharmaceutical Factory obtained the manufacturing and marketing approval of "ELNEOPA-NF No. 1 Injection and ELNEOPA-NF No. 2 Injection"
May 10, 2016: Otsuka Pharmaceutical Factory and Lilium Otsuka sign Japanese-market sales partnership agreement for the medical device "Lilium^Ⓡ α-200"
March 2, 2016: Otsuka Pharmaceutical Factory changes the flavor and packaging of its Oral Rehydration Solution "OS-1^Ⓡ"
September 16, 2015: Otsuka Pharmaceutical Factory launches the antiseptics for external use "Olanedine"
August 19, 2015: Otsuka Pharmaceutical Factory announces changes in the packaging container and volume of "Oronine^Ⓡ H Ointment" (from now available in an 11-g tube size)
July 6, 2015: Otsuka Pharmaceutical Factory obtained the marketing approval of antiseptics for external use "Olanedine"
October 10, 2014: Otsuka Pharmaceutical Factory enters into a license agreement on bioengineered pancreatic islet "DIABECELL^Ⓡ" as a treatment for diabetes
September 5, 2014: Otsuka Pharmaceutical Factory announces "PROCESS LEAD", a chew and swallow managing food
July 9, 2014: J.O.Pharma Co., Ltd. to expand its production facility in Izumo City
June 17, 2014: Egypt Otsuka acquires an Egyptian intravenous infusion manufacturing and distribution company.
June 16, 2014: Otsuka Pharmaceutical Factory announces personnel changes
June 2, 2014: Otsuka Pharmaceutical Factory launches "RACOL-NF Semi Solid for Enteral Use"
February 24, 2014: Otsuka Pharmaceutical Factory announces "HINE E-GEL" concentrated liquid nutrition product
October 25, 2013: Otsuka Pharmaceutical Factory launches a newly approved plasma substitute "Voluven^Ⓡ 6%"
July 29, 2013: Otsuka Techno takes an equity interest in a Chinese firm that manufactures and markets plastic caps for IV solution-related products
May 22, 2013: Otsuka Pharmaceutical Factory and Fresenius Kabi Japan enter into an exclusive distribution agreement of HES products, including the newly approved "Voluven 6%"
December 7, 2012: Otsuka Pharmaceutical Factory and Mitsui enter into IV solutions business in India
December 14, 2011: Otsuka Techno to construct new factory at industrial park in Naruto, Tokushima
November 28, 2011: J.O. Pharma Co., Ltd. to construct a new manufacturing facility for prefilled syringes (a syringe with injectable drug solution filled in advance): Signing of an agreement with Shimane Prefecture and Izumo City for the facility construction
April 12, 2011: Otsuka Pharmaceutical Factory invests in Living Cell Technologies Limited, a biotechnology company advancing development of encapsulated porcine pancreatic islet replacement treatment
January 28, 2011: Otsuka Techno and Otsuka Pharmaceutical Factory take an equity interest in a Chinese firm that manufactures and markets plastic film for IV solution bags